|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 95.59 USD | -1.95% |
|
-5.94% | +17.87% |
| 05-12 | Lemaitre Vascular Insider Sold Shares Worth $5,032,413, According to a Recent SEC Filing | MT |
| 05-11 | Lemaitre Vascular Insider Sold Shares Worth $313,287, According to a Recent SEC Filing | MT |
Company Valuation: LeMaitre Vascular, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,097 | 1,012 | 1,264 | 2,072 | 1,840 | 2,184 | - | - |
| Change | - | -7.7% | 24.81% | 63.94% | -11.19% | 18.72% | - | - |
| Enterprise Value (EV) 1 | 1,097 | 1,012 | 1,264 | 2,072 | 1,840 | 1,933 | 1,870 | 2,184 |
| Change | - | -7.7% | 24.81% | 63.94% | -11.19% | 5.07% | -3.25% | 16.79% |
| P/E | 40.2x | 49.5x | 42.4x | 47.7x | 32.2x | 31.9x | 29.4x | 27.2x |
| PBR | - | - | - | - | - | 4.78x | 4.19x | - |
| PEG | - | -1.9x | 1x | 1.1x | 1.1x | 1.7x | 3.45x | 3.48x |
| Capitalization / Revenue | 7.1x | 6.26x | 6.53x | 9.42x | 7.37x | 7.8x | 7.14x | 6.56x |
| EV / Revenue | 7.1x | 6.26x | 6.53x | 9.42x | 7.37x | 6.9x | 6.12x | 6.56x |
| EV / EBITDA | 24x | 25.9x | 27.5x | 33.6x | 24.8x | 21.2x | 18.6x | 19.5x |
| EV / EBIT | 30.1x | 33.8x | 34.4x | 39.6x | 27.1x | 24.1x | 21x | 22.2x |
| EV / FCF | 36.3x | 45.7x | 42.9x | 55.7x | 24.7x | 27.8x | 21.8x | 23.8x |
| FCF Yield | 2.75% | 2.19% | 2.33% | 1.79% | 4.05% | 3.6% | 4.58% | 4.21% |
| Dividend per Share 2 | 0.44 | 0.5 | 0.56 | 0.64 | 0.8 | 1 | 1.12 | - |
| Rate of return | 0.88% | 1.09% | 0.99% | 0.69% | 0.99% | 1.05% | 1.17% | - |
| EPS 2 | 1.25 | 0.93 | 1.34 | 1.93 | 2.52 | 3 | 3.256 | 3.51 |
| Distribution rate | 35.2% | 53.8% | 41.8% | 33.2% | 31.7% | 33.3% | 34.4% | - |
| Net sales 1 | 154.4 | 161.7 | 193.5 | 219.9 | 249.6 | 280 | 305.8 | 332.8 |
| EBITDA 1 | 45.78 | 39.04 | 45.91 | 61.74 | 74.31 | 90.97 | 100.5 | 111.9 |
| EBIT 1 | 36.42 | 29.94 | 36.71 | 52.26 | 67.91 | 80.24 | 89.17 | 98.25 |
| Net income 1 | 26.91 | 20.64 | 30.1 | 44.04 | 57.73 | 69.28 | 75.98 | 83.44 |
| Net Debt 1 | - | - | - | - | - | -251.2 | -314.1 | - |
| Reference price 2 | 50.23 | 46.02 | 56.76 | 92.14 | 81.10 | 95.59 | 95.59 | 95.59 |
| Nbr of stocks (in thousands) | 21,838 | 22,001 | 22,263 | 22,484 | 22,686 | 22,851 | - | - |
| Announcement Date | 2/24/22 | 2/23/23 | 2/27/24 | 2/27/25 | 2/25/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 31.86x | 6.9x | 21.25x | 1.05% | 2.18B | ||
| 28.31x | 5.12x | 19.63x | 0.32% | 211B | ||
| 31.99x | 5.88x | 18.61x | 0.77% | 135B | ||
| 36.98x | 9.57x | 21.13x | -.--% | 119B | ||
| 15.82x | 3.35x | 10.81x | -.--% | 65.77B | ||
| 31.71x | 6.5x | 20.56x | -.--% | 47.58B | ||
| 18.58x | 2.14x | 11.09x | 2.82% | 44.44B | ||
| 26.95x | 5.36x | 18.32x | 0.74% | 39.14B | ||
| 45.41x | 6.34x | 19.47x | -.--% | 36.79B | ||
| 41.41x | 6.53x | 23.25x | -.--% | 29.37B | ||
| Average | 30.90x | 5.77x | 18.41x | 0.57% | 73.03B | |
| Weighted average by Cap. | 30.23x | 5.87x | 18.51x | 0.45% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- LMAT Stock
- Valuation LeMaitre Vascular, Inc.
Select your edition
All financial news and data tailored to specific country editions
















